MedPath

ational survey for chemotherapy-induced nausea and vomiting

Not Applicable
Conditions
malignant neoplasm
Registration Number
JPRN-UMIN000005971
Lead Sponsor
Survey on CINV Scientific Committee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
2000
Inclusion Criteria

Not provided

Exclusion Criteria

patients who had experienced nausea and vomiting within 24 hours prior to the start of chemotherapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath